Special Issue: Discovery of Novel Antidepressants and Anxiolytics

Authors

James Oluwagbamigbe Fajemiroye (ORCID: https://orcid.org/0000-0001-7440-7581)
Gunnar P.H. Dietz (ORCID: https://orcid.org/0000-0001-9395-8442)

Institutions

Universidade Evangelica de Goiás (BR)
Universidade Federal de Goiás (BR)
University of Göttingen (DE)

Publication Details

Journal: Pharmaceuticals
Published: 2026-09-29
DOI: https://doi.org/10.3390/ph19101541
Primary Topic: Treatment of Major Depression
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

article

Special Issue: Discovery of Novel Antidepressants and Anxiolytics

James Oluwagbamigbe Fajemiroye, Gunnar P.H. Dietz

Sep 29, 2026

Pharmaceuticals

Treatment of Major Depression

article

Special Issue: Discovery of Novel Antidepressants and Anxiolytics

James Oluwagbamigbe Fajemiroye, Gunnar P.H. Dietz

September 29, 2026article en

Abstract

No abstract available for this paper.

PharmaceuticalsVol. 19(10)

Universidade Evangelica de Goiás (BR), Universidade Federal de Goiás (BR), University of Göttingen (DE)

Openalex Percentile: Top 13%

Treatment of Major Depression

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Special Issue: Discovery of Novel Antidepressants and Anxiolytics — James Oluwagbamigbe Fajemiroye, Gunnar P.H. Dietz · Pharmaceuticals (2026) | TGRS Research Map | TGRS